The combined use of proton pump inhibitors and antibiotics as risk factors for Clostridium difficile infection

Daniel S. Kassavin, David Pham, Linda Pascarella, Kuo Yen-Hong, Michael A. Goldfarb

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose A review of the incidence of Clostridium. difficile infection (CDI) at our hospital was performed due to the morbidity of CDI in its fulminate form, reports of the increased incidence of CDI in the United States and the increased use of medications associated with its onset. Methods The study was retrospective and took place over a 9-month period, from 1 January 2009 through 30 September 2009. Results There were 88 cases of CDI in the course of the review which amounted to 5.1 infections per 1000 patient hospital admissions. The percentage of overall admissions that were prescribed antibiotics and proton pump inhibitors (PPI), PPI alone or antibiotics alone were 17.1%, 15.5% and 24.3%, respectively. Of all cases of CDI, 59.1% of patients were on both a PPI and antibiotic, 9.1% were on a PPI alone and 13.6% were on an antibiotic alone. Patients on both proton pump inhibitors and antibiotics had an odds ratio of 8.30 (P

Original languageEnglish (US)
Pages (from-to)76-79
Number of pages4
JournalHealthcare Infection
Volume18
Issue number2
DOIs
StatePublished - Jun 2013
Externally publishedYes

Fingerprint

Clostridium Infections
Clostridium difficile
Proton Pump Inhibitors
Anti-Bacterial Agents
Clostridium
Patient Admission
Incidence
Infection
Retrospective Studies
Odds Ratio
Morbidity

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

The combined use of proton pump inhibitors and antibiotics as risk factors for Clostridium difficile infection. / Kassavin, Daniel S.; Pham, David; Pascarella, Linda; Yen-Hong, Kuo; Goldfarb, Michael A.

In: Healthcare Infection, Vol. 18, No. 2, 06.2013, p. 76-79.

Research output: Contribution to journalArticle

Kassavin, Daniel S. ; Pham, David ; Pascarella, Linda ; Yen-Hong, Kuo ; Goldfarb, Michael A. / The combined use of proton pump inhibitors and antibiotics as risk factors for Clostridium difficile infection. In: Healthcare Infection. 2013 ; Vol. 18, No. 2. pp. 76-79.
@article{734105d0ca6646e39fc17b20c94386c0,
title = "The combined use of proton pump inhibitors and antibiotics as risk factors for Clostridium difficile infection",
abstract = "Purpose A review of the incidence of Clostridium. difficile infection (CDI) at our hospital was performed due to the morbidity of CDI in its fulminate form, reports of the increased incidence of CDI in the United States and the increased use of medications associated with its onset. Methods The study was retrospective and took place over a 9-month period, from 1 January 2009 through 30 September 2009. Results There were 88 cases of CDI in the course of the review which amounted to 5.1 infections per 1000 patient hospital admissions. The percentage of overall admissions that were prescribed antibiotics and proton pump inhibitors (PPI), PPI alone or antibiotics alone were 17.1{\%}, 15.5{\%} and 24.3{\%}, respectively. Of all cases of CDI, 59.1{\%} of patients were on both a PPI and antibiotic, 9.1{\%} were on a PPI alone and 13.6{\%} were on an antibiotic alone. Patients on both proton pump inhibitors and antibiotics had an odds ratio of 8.30 (P",
author = "Kassavin, {Daniel S.} and David Pham and Linda Pascarella and Kuo Yen-Hong and Goldfarb, {Michael A.}",
year = "2013",
month = "6",
doi = "10.1071/HI12039",
language = "English (US)",
volume = "18",
pages = "76--79",
journal = "Infection, Disease and Health",
issn = "2468-0451",
publisher = "Australasian College for Infection Prevention and Control (ACIPC)",
number = "2",

}

TY - JOUR

T1 - The combined use of proton pump inhibitors and antibiotics as risk factors for Clostridium difficile infection

AU - Kassavin, Daniel S.

AU - Pham, David

AU - Pascarella, Linda

AU - Yen-Hong, Kuo

AU - Goldfarb, Michael A.

PY - 2013/6

Y1 - 2013/6

N2 - Purpose A review of the incidence of Clostridium. difficile infection (CDI) at our hospital was performed due to the morbidity of CDI in its fulminate form, reports of the increased incidence of CDI in the United States and the increased use of medications associated with its onset. Methods The study was retrospective and took place over a 9-month period, from 1 January 2009 through 30 September 2009. Results There were 88 cases of CDI in the course of the review which amounted to 5.1 infections per 1000 patient hospital admissions. The percentage of overall admissions that were prescribed antibiotics and proton pump inhibitors (PPI), PPI alone or antibiotics alone were 17.1%, 15.5% and 24.3%, respectively. Of all cases of CDI, 59.1% of patients were on both a PPI and antibiotic, 9.1% were on a PPI alone and 13.6% were on an antibiotic alone. Patients on both proton pump inhibitors and antibiotics had an odds ratio of 8.30 (P

AB - Purpose A review of the incidence of Clostridium. difficile infection (CDI) at our hospital was performed due to the morbidity of CDI in its fulminate form, reports of the increased incidence of CDI in the United States and the increased use of medications associated with its onset. Methods The study was retrospective and took place over a 9-month period, from 1 January 2009 through 30 September 2009. Results There were 88 cases of CDI in the course of the review which amounted to 5.1 infections per 1000 patient hospital admissions. The percentage of overall admissions that were prescribed antibiotics and proton pump inhibitors (PPI), PPI alone or antibiotics alone were 17.1%, 15.5% and 24.3%, respectively. Of all cases of CDI, 59.1% of patients were on both a PPI and antibiotic, 9.1% were on a PPI alone and 13.6% were on an antibiotic alone. Patients on both proton pump inhibitors and antibiotics had an odds ratio of 8.30 (P

UR - http://www.scopus.com/inward/record.url?scp=84878296700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878296700&partnerID=8YFLogxK

U2 - 10.1071/HI12039

DO - 10.1071/HI12039

M3 - Article

AN - SCOPUS:84878296700

VL - 18

SP - 76

EP - 79

JO - Infection, Disease and Health

JF - Infection, Disease and Health

SN - 2468-0451

IS - 2

ER -